Sivik Global Healthcare’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Sivik Global Healthcare’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-25,000	Closed	-$4.31M	–	60
2019 Q2	$4.31M	Sell	25,000 -5,000	-17%	-$865K	1.04%	28
2019 Q1	$5.06M	Buy	30,000 +25,000	+500%	+$3.72M	1.86%	26
2018 Q4	$487K	Sell	5,000 -22,500	-82%	-$2.95M	0.26%	47
2018 Q3	$4.75M	Buy	+27,500	New	+$3.97M	1.7%	28
2018 Q1	–	Sell	-30,000	Closed	-$3.96M	–	71
2017 Q4	$3.96M	Buy	30,000 +5,000	+20%	+$587K	1.47%	30
2017 Q3	$2.54M	Sell	25,000 -5,000	-17%	-$535K	0.86%	41
2017 Q2	$3.01M	Sell	30,000 -5,200	-15%	-$560K	1.1%	41
2017 Q1	$4.26M	Buy	35,200 +7,500	+27%	+$920K	1.98%	24
2016 Q4	$3.1M	Hold	27,700	–	–	1.48%	27
2016 Q3	$3.68M	Sell	27,700 -2,300	-8%	-$220K	1.85%	27
2016 Q2	$2.75M	Buy	30,000 +10,000	+50%	+$842K	1.37%	39
2016 Q1	$1.44M	Buy	+20,000	New	+$1.1M	0.64%	53

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sivik Global Healthcare's GWPH Position: Q3 2019 in Review

Sivik Global Healthcare sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2019, closing a stake of 25,000 shares — an estimated $4.31M sold.

Sivik Global Healthcare first reported a position in GWPH in Q1 2016 and held it in 12 quarters. The position peaked at $5.06M in Q1 2019. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

Sivik Global Healthcare reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
Sivik Global Healthcare sold 25,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $4.31M.
Sivik Global Healthcare first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2016 and held it in 12 quarters.
Sivik Global Healthcare's GW Pharmaceuticals Plc American Depositary Shares position peaked at $5.06M in Q1 2019.
316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Sivik Global Healthcare's 13F filing for Q3 2019, filed 12 Nov 2019.